Stick With Neostigmine for Most Neuromuscular Blockade Reversal
February 2016
Sugammadex (Bridion, BRID-ee-un) will be the first neuromuscular blocker (NMB) reversal agent approved in the U.S. in 30 years.
We usually see neostigmine given to reverse NMBs (rocuronium, etc). Muscarinic blockers (glycopyrrolate, atropine) must also be given to limit neostigmine's side effects...hypotension, bradycardia, etc.
But some anesthesiologists don't like that neostigmine can take 20 minutes to work and may result in residual blockade.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote